Results 151 to 160 of about 836,777 (260)

Mucuna pruriens as a Sustainable Functional Food: Applications From Seed to Product

Modern Agriculture, Volume 4, Issue 2, December 2026.
This review highlights Mucuna pruriens as a nutrient‐rich legume with significant nutritional, therapeutic, and agricultural value. Its protein‐rich seeds contain essential minerals and L‐DOPA, but high antinutritional compounds require effective processing before consumption.
Crossby Osei Tutu, Reuben Acheampong, Papa Toah Akonor, Bernard Kwabena Asiedu, Rexford Obeng, Anthonia Helga Andoh‐Odoom, Dora Duah‐Bisiw, Jacob Ulzen, Michael Wiafe‐Kwagyan, Nii Korley Kortei, Justice Owusu‐Bempah   +10 more
wiley   +1 more source

Pancreatic neuroendocrine tumors in patients with tuberous sclerosis: a multicenter study and systematic review. [PDF]

J Endocr Soc
Shekhda KM, Howat J, Gao Y, Bel-Ange A, Grozinsky-Glasberg S, Kaltsas G, Ho KMA, Hayes AR, Mandair D, Toumpanakis C, Karra E, Dixon RA, Donnelly D, Jones EA, Jones CH, O'Callaghan F, Sharma A, Slaney K, Frydman A, Srirajaskanthan R, Kibrya N, Caplin M, Elmslie F, Grossman A.   +23 more
europepmc   +1 more source

[68Ga]-DOTATOC PET/CT Volumetric Parameters Reflect Metastatic Potential in Pancreatic Neuroendocrine Tumors

Background: [68Ga]-DOTATOC PET/CT is a valuable technique for identifying neuroendocrine tumors overexpressing somatostatin receptors; however, its diagnostic and prognostic utility for WHO low-grade pancreatic neuroendocrine tumors remains unclear ...
Si Young Song, Arthur Cho, Seung Woo Park, Moon Jae Chung, Jung Hyun Jo, Seungmin Bang, Jeong Youp Park, Hee Seung Lee, So Jeong Kim, Jongtae Cha   +9 more
core   +1 more source

Curative‐Intent Pancreatectomy for Pancreatic Metastasis From Renal Cell Carcinoma 30 Years After Nephrectomy Following Lenvatinib Plus Pembrolizumab Therapy: A Case Report

IJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Renal cell carcinoma (RCC) is the most common primary site of pancreatic metastases, and complete resection confers a favorable prognosis. Lenvatinib plus pembrolizumab (LEN + PEM) is standard first‐line therapy for advanced RCC; however, induction therapy before resection of pancreatic metastasis has not been reported.
Yuta Kaneko, Reo Kotorii, Kaishi Shimizu, Kazuma Miura, Yosuke Nakanishi, Ken Nakamura, Seiya Hattori, Yasuto Yagi, Toru Nishiyama, Tetsuo Momma   +9 more
wiley   +1 more source

Multiple Incidental Pancreatic Neuroendocrine Tumors in a Patient With Suspected Duodenal Papillary Adenocarcinoma: A Case Report. [PDF]

Cureus
Junqueira F, Pedrão Ferreira MH, Mancilla Lourenço L, Vicente Juliano H, Artifon E.   +4 more
europepmc   +1 more source

In Situ Self‐Assembled Molecular Fortifying Agent for Enhanced Retention and Therapeutic Efficacy of Radiopharmaceuticals

Aggregate, Volume 7, Issue 10, October 2026.
A molecular‐fortifying agent strategy based on in situ self‐assembly is developed to prolong tumor retention of radioligands. After tumor‐targeting, FAP‐α cleavage triggers nanofiber formation, presenting azide anchors for bioorthogonal capture of pre‐accumulated radioligands.
Daojia Liu, Xiaoqin Luo, Xiaojuan Wang, Xing Liu, Fanglei Zhang, Pan Wang, Jibin Song, Junqiang Chen   +7 more
wiley   +1 more source

Procedure-specific morbidity and pathologic assessment after resection of small (≤20 mm) pancreatic neuroendocrine tumors. [PDF]

J Neuroendocrinol
Maekawa A, Perri G, Partelli S, de Ponthaud C, Dokmak S, Jäger C, Luzietti ML, Marchetti A, Andreasi V, Battistella A, Yilmaz BS, Sheel A, Rajput K, Hu H, Cillo U, Sauvanet A, Friess H, Baron RD, Gaujoux S, Falconi M, Marchegiani G.   +20 more
europepmc   +1 more source

Lanreotide, a Somatostatin Analogue, in Advanced Merkel Cell Carcinoma: A Prospective Single‐Arm Phase II Study

Cancer Medicine, Volume 15, Issue 10, October 2026.
ABSTRACT Background Merkel Cell Carcinoma (MCC) is a rare, aggressive neuroendocrine and epithelial skin cancer. Somatostatin analogues, such as lanreotide, have shown efficacy in managing other neuroendocrine tumors. Retrospective studies suggest that lanreotide may induce partial response or disease stabilization in patients with advanced MCC.
Julie Charles, Aude Belbezier, Stéphane Mouret, Brigitte Dreno, Stéphane Dalle, Céleste Lebbe, Ewa Hainaut‐Wierzbicka, Andreea Stefan, Julie de Quatrebarbes, Olivier Dereure, Ouidad Zehou, Sandrine Mansard, Alain Dupuy, Caroline Dutriaux, Florent Grange, Caroline Gaudy‐Marqueste, Henri Montaudié, Jean‐Philippe Arnault, Yannick Le Corre, Thibault Kervarrec, Jean‐Louis Quesada, Mahtab Samimi, Marie‐Thérèse Leccia, The Group of Cutaneous Oncology of the French Society of Dermatology   +23 more
wiley   +1 more source

Long-term survival and molecular heterogeneity of sporadic multifocal non-functional pancreatic neuroendocrine tumors. [PDF]

iScience
Peng Y, Yin L, Lu Z, Guo F, Chen J, Tu M, Gao Y, Gao W, Wei J, Li Q, Jiang K, Wu J.   +11 more
europepmc   +1 more source

Antitumor effects of lanreotide for pancreatic and intestinal neuroendocrine tumors.

, 2016
Antitumor effects of lanreotide for pancreatic and intestinal neuroendocrine ...
Rindi, Guido
core